Skip to main content
. 2012 Aug 21;8(12):1850–1853. doi: 10.4161/hv.21735

Table 2. Persistence of influenza vaccine-induced antibody.

Vaccine Virus 1 y 2 y 2.5 y 3 y
 
Healthy
Transplant
Healthy
Transplant
Healthy
Transplant
Healthy
Transplant
2006–07
A/New Caledonia
H1N1
15/15 (100%)
46/46 (100%)
9/9 (100%)
34/46 (74%)


6/9 (67%)
11/38 (29%)
2007–08
A/Solomon Islands H1N1
23/23 (100%)
46/46 (100%)
18/23 (78%)
30/46 (65%)
8/21 (38%)
12/34 (35%)


2004–05 A/Wyoming H3N2
18/18 (100%)
57/57 (100%)
14/18 (78%)
35/52 (67%)


4/15 (27%)
7/51 (8%)
2007–08 A/Wisconsin H3N2
22/22 (100%)
47/47 (100%)
17/22 (77%)
31/47 (66%)
6/21 (29%)
16/35 (46%)


2004–05 B/Shanghai
22/22 (100%)
40/40 (100%)
8/21 (38%)
20/40 (50%)


1/18 (6%)
7/31 (23%)
2007–08 B/Malaysia 19/19 (100%) 45/45 (100%) 3/19 (16%) 12/45 (27%) 1/17 (6%) 5/34 (15%)

All between group comparisons not statistically significant by Fisher’s exact test. All between season comparisons statistically significant different by Fisher’s exact test except control 2006 A/New Caledonia year 1 vs. year 2 vs. year 3 and control and transplant 2007 B/Malaysia year 2 vs. year 2.5.